VIENNA — Ribbon Biolabs, the DNA synthesis company, today announced the appointment of Jodi Barrientos as Chief Business Officer. With over 17 years of experience in industry-leading life science and diagnostics companies, Jodi Barrientos brings deep knowledge and expertise in commercial strategy, operations, and enterprise development focused on key synthetic biology and genomics markets. In […]
We’re excited to announce that Grace DeSantis has joined ONI as VP Biology & Chemistry. Grace will be driving our Bioware function, and leading our Applications Development and Chemistry teams between Oxford and San Diego. Grace joins us from her executive R&D role at Illumina, where she oversaw R&D, clinical product innovation and product development for 9 […]
Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is establishing a team in the United States. The company has appointed Oladimeji Fashola as Chief Technology Officer, and Business Development team of three. These crucial additions mark an exciting phase of growth for the company and underline its commitment to expanding its presence in the U.S. market. The fast […]
Marcus Kuhnert will step down as Chief Financial Officer and Member of the Executive Board after a successful nine-year tenure Helene von Roeder appointed Chief Financial Officer and Executive Board Member, effective July 1, 2023 Darmstadt, Germany – Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board […]
Nanologica AB (publ) has decided to focus on Chromatography and the management team is adapted to reflect the new business focus. In order to create the best conditions for success in preparative chromatography, the company’s operations are focused on Chromatography and the Drug Development operations are down-prioritized and placed in subsidiaries for future opportunities. The […]
Rainer Lehmann to step down as Chief Financial Officer later this year; Sartorius commences search process Göttingen — Sartorius’ Chief Financial Officer Rainer Lehmann will step down from his position by the end of October 2023 to pursue a new opportunity outside the company. The Supervisory Board of Sartorius AG has initiated a search process […]
Changes are afoot at Swiss company evitria: As of May, Dr. Stefan Schmidt will take over the helm of the company, which specializes in the production of recombinant antibodies for medicine and research. Since 2010, evitria, based in Schlieren near Zurich, has specialized in the production of antibodies and other proteins. Today, evitria, part of a group consisting […]
Appointment positions company for strategic growth in next-generation protein sequencing GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer, effective May 15, 2023. Mr. Keyes brings more than 25 years of experience in senior financial positions providing transformational leadership for emerging […]
Cambridge, UK: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Kenneth Hitchner, BA MBA, as Chairman of its Board of Directors. The announcement follows a series of appointments to the Company’s senior leadership team, as part of its ambitious global growth strategy. […]
Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), today announced that Jonathan Kalstein is joining the company as Chief Financial Officer. Jonathan brings more than 25 years of financial and operations experience to help ATL scale in a period of continued growth. A proven leader, Jonathan has an impressive record […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
